200 related articles for article (PubMed ID: 7894971)
1. Antineoplastic activity of benzimidazo[1,2-b]-isoquinolines, indolo[2,3-b]quinolines, and pyridocarbazoles.
Weinkauf RL; Chen AY; Yu C; Liu L; Barrows L; LaVoie EJ
Bioorg Med Chem; 1994 Aug; 2(8):781-6. PubMed ID: 7894971
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro antitumor activity of novel 2-alkyl-5-methoxycarbonyl-11-methyl-6H-pyrido[4,3-b]carbazol-2-ium and 2-alkylellipticin-2-ium chloride derivatives.
Mori R; Kato A; Komenoi K; Kurasaki H; Iijima T; Kawagoshi M; Kiran YB; Takeda S; Sakai N; Konakahara T
Eur J Med Chem; 2014 Jul; 82():16-35. PubMed ID: 24863982
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors.
Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J
J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity of some ellipticine-like 11H-pyrido[a]carbazole derivatives.
Ferlin MG; Gia O; Dalla Via L
ChemMedChem; 2011 Oct; 6(10):1872-83. PubMed ID: 21826796
[TBL] [Abstract][Full Text] [Related]
5. DNA binding ellipticine analogues: synthesis, biological evaluation, and structure-activity relationships.
Ferlin MG; Marzano C; Gandin V; Dall'Acqua S; Dalla Via L
ChemMedChem; 2009 Mar; 4(3):363-77. PubMed ID: 19197924
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer activity of new 1-substituted-6H-pyrido[4,3-b]carbazole derivatives.
Tylińska B; Jasztold-Howorko R; Mastalarz H; Szczaurska-Nowak K; Wietrzyk J
Arch Pharm (Weinheim); 2008 Jun; 341(6):351-6. PubMed ID: 18404778
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 4-amino-substituted 7-methoxy (and 7-hydroxy)- 11-methyl (and 5,11-dimethyl)-10H-pyrido [2,3-b] carbazoles and 4-amino- substituted 11-methyl (and 5,11-dimethyl)-10H-pyrido[3',4':4,5] pyrrolo [3,2-g] quinolines, two new series related to antitumor ellipticine derivatives.
Moron J; Rautureau M; Huel C; Pierré A; Berthier LK; Atassi G; Bisagni E
Anticancer Drug Des; 1993 Dec; 8(6):399-416. PubMed ID: 8286009
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors.
Kaczmarek L; Peczyńska-Czoch W; Osiadacz J; Mordarski M; Sokalski WA; Boratyński J; Marcinkowska E; Glazman-Kuśnierczyk H; Radzikowski C
Bioorg Med Chem; 1999 Nov; 7(11):2457-64. PubMed ID: 10632055
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Human Topoisomerase II by N,N,N-Trimethylethanammonium Iodide Alkylcarbazole Derivatives.
Saturnino C; Caruso A; Iacopetta D; Rosano C; Ceramella J; Muià N; Mariconda A; Bonomo MG; Ponassi M; Rosace G; Sinicropi MS; Longo P
ChemMedChem; 2018 Dec; 13(24):2635-2643. PubMed ID: 30347518
[TBL] [Abstract][Full Text] [Related]
11. New pyridocarbazole derivatives. Synthesis and their in vitro anticancer activity.
Jasztold-Howorko R; Tylińska B; Biaduń B; Gebarowski T; Gasiorowski K
Acta Pol Pharm; 2013; 70(5):823-32. PubMed ID: 24147360
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Interactions of Selected Olivacine Derivatives with DNA and Topoisomerase II.
Tylińska B; Dobosz A; Spychała J; Cwynar-Zając Ł; Czyżnikowska Ż; Kuźniarski A; Gębarowski T
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445198
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological properties of some 6H-pyrido[4,3-b]carbazoles.
Archer S; Ross BS; Pica-Mattoccia L; Cioli D
J Med Chem; 1987 Jul; 30(7):1204-10. PubMed ID: 3599025
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of ferrocenyl indeno[1,2-c]isoquinolines as topoisomerase II inhibitors.
Wambang N; Schifano-Faux N; Aillerie A; Baldeyrou B; Jacquet C; Bal-Mahieu C; Bousquet T; Pellegrini S; Ndifon PT; Meignan S; Goossens JF; Lansiaux A; Pélinski L
Bioorg Med Chem; 2016 Feb; 24(4):651-60. PubMed ID: 26740155
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of 5-aza-ellipticine derivatives.
Moody DL; Dyba M; Kosakowska-Cholody T; Tarasova NI; Michejda CJ
Bioorg Med Chem Lett; 2007 Apr; 17(8):2380-4. PubMed ID: 17376678
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c]carbazoles as a new class of anti-cancer agents.
Pierce LT; Cahill MM; Winfield HJ; McCarthy FO
Eur J Med Chem; 2012 Oct; 56():292-300. PubMed ID: 22910137
[TBL] [Abstract][Full Text] [Related]
17. Activity of nitrogen-containing and non-nitrogen-containing bisphosphonates on tumor cell lines.
Zhang Y; Leon A; Song Y; Studer D; Haase C; Koscielski LA; Oldfield E
J Med Chem; 2006 Sep; 49(19):5804-14. PubMed ID: 16970405
[TBL] [Abstract][Full Text] [Related]
18. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L
Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties of novel indeno[2,1-c]quinolin-7-one and indeno[1,2-c]isoquinolin-5,11-dione derivatives.
Ryckebusch A; Garcin D; Lansiaux A; Goossens JF; Baldeyrou B; Houssin R; Bailly C; Hénichart JP
J Med Chem; 2008 Jun; 51(12):3617-29. PubMed ID: 18507368
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of new penta- and heptacyclic indolo- and quinolinocarbazole ring systems obtained via Pd(0) catalysed reductive N-heteroannulation.
Laronze-Cochard M; Cochard F; Daras E; Lansiaux A; Brassart B; Vanquelef E; Prost E; Nuzillard JM; Baldeyrou B; Goosens JF; Lozach O; Meijer L; Riou JF; Henon E; Sapi J
Org Biomol Chem; 2010 Oct; 8(20):4625-36. PubMed ID: 20734015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]